SCP — Scope Fluidics SA Share News
0.000.00%
Last trade - 00:00- PLN413.78m
- PLN296.81m
- PLN0.10m
Brief: Scope Fluidics Q2 Net Loss At 10.1 Million Zlotys
Brief: Scope Fluidics Unit Signs Deal With Poland's PARP For Up To 14.4 Mln Zlotys In Funding For HYBOLIC Project
Brief: Scope Fluidics Says FDA Certification For UNI FAST Panel Planned For Second Half Of 2027
Brief: Scope Fluidics Extends Deadline For First Goal In Hybolic Project
Brief: Scope Fluidics Granted US Patent For Bacteromic Microorganism Growth Prediction System With AI
Brief: Scope Fluidics Says Its Unit Edocera Conditionally Granted 12.2 Mln Zloty Subsidy
Brief: Scope Fluidics Unit Signs Distribution Deal With Biomedica Medizinprodukte
Brief: Scope Fluidics' Bacteromic Signs Agreement With Comac Medical For Clinical Trials Of Bacteromic PBC Panel
Brief: Scope Fluidics Says Bacteromic Buys New Location For Semi-Automated Bacteromic Panel Production Line
Brief: Scope Fluidics Extends Deadline For First Milestone Of Hybolic Project To End Of Q3 2026
Brief: Scope Fluidics Says Bacteromic Granted U.S. Patent 'Microfluidic Chip'
Brief: Scope Fluidics Q1 Net Loss At 13.5 Million Zlotys
Brief: Scope Fluidics Unit Bacteromic Starts Collaboration With US Research Center For FDA Registration Trials
Brief: Scope Fluidics FY Net Loss At 46.4 Million Zlotys
Brief: Scope Fluidics Updates Objectives For Bacteromic Project For 2026-2027
Brief: Scope Fluidics Obtains CE-IVDR Certification For Bacteromic System
Brief: Scope Fluidics Unit Adopts Plan For Production Readiness For Bacteromic System Panels
Brief: Scope Fluidics Unit Signs Framework Distribution Deal With SC Elta 90 Medical Research
Brief: Scope Fluidics Signs Distribution Deal For Bacteromic System In Turkey